1. Home
  2. MATW vs CTMX Comparison

MATW vs CTMX Comparison

Compare MATW & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$19.20

Market Cap

639.2M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$2.68

Market Cap

716.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
CTMX
Founded
1850
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.2M
716.9M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
MATW
CTMX
Price
$19.20
$2.68
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $12.10
AVG Volume (30 Days)
825.4K
★ 3.9M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
★ 3.67%
N/A
EPS Growth
★ 59.07
N/A
EPS
N/A
★ N/A
Revenue
★ $1,795,737,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
★ N/A
$22.58
Revenue Growth
★ N/A
N/A
52 Week Low
$18.69
$2.60
52 Week High
$30.93
$8.21

Technical Indicators

Market Signals
Indicator
MATW
CTMX
Relative Strength Index (RSI) 34.19 34.71
Support Level N/A N/A
Resistance Level $20.63 $3.93
Average True Range (ATR) 0.62 0.19
MACD 0.09 -0.03
Stochastic Oscillator 23.97 9.78

Price Performance

Historical Comparison
MATW
CTMX

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: